(NASDAQ: AGEN) Agenus's forecast annual revenue growth rate of 7.32% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.8%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.37%.
Agenus's revenue in 2026 is $114,196,000.On average, 5 Wall Street analysts forecast AGEN's revenue for 2026 to be $7,077,968,593, with the lowest AGEN revenue forecast at $4,299,463,697, and the highest AGEN revenue forecast at $9,353,839,034. On average, 5 Wall Street analysts forecast AGEN's revenue for 2027 to be $4,809,777,822, with the lowest AGEN revenue forecast at $4,112,847,697, and the highest AGEN revenue forecast at $5,523,603,223.
In 2028, AGEN is forecast to generate $5,996,286,961 in revenue, with the lowest revenue forecast at $3,514,678,138 and the highest revenue forecast at $9,479,017,668.